Cargando…
Negligible exposure to nifurtimox through breast milk during maternal treatment for Chagas Disease
BACKGROUND: Treatment with nifurtimox (NF) for Chagas disease is discouraged during breast-feeding because no information on NF transfer into breast milk is available. NF is safe and effective for paediatric and adult Chagas disease. We evaluated the degree of NF transfer into breast milk in lactati...
Autores principales: | Moroni, Samanta, Marson, Maria Elena, Moscatelli, Guillermo, Mastrantonio, Guido, Bisio, Margarita, Gonzalez, Nicolas, Ballering, Griselda, Altcheh, Jaime, García-Bournissen, Facundo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711540/ https://www.ncbi.nlm.nih.gov/pubmed/31415566 http://dx.doi.org/10.1371/journal.pntd.0007647 |
Ejemplares similares
-
Population Pharmacokinetic Study of Benznidazole in Pediatric Chagas Disease Suggests Efficacy despite Lower Plasma Concentrations than in Adults
por: Altcheh, Jaime, et al.
Publicado: (2014) -
Prevention of congenital Chagas through treatment of girls and women of
childbearing age
por: Moscatelli, Guillermo, et al.
Publicado: (2015) -
Longitudinal follow up of serological response in children treated for Chagas disease
por: Moscatelli, Guillermo, et al.
Publicado: (2019) -
Abdominal Cystic Echinococcosis Treated with Albendazole. A Pediatric Cohort Study
por: Moroni, Samanta, et al.
Publicado: (2016) -
Biopharmaceutical Characteristics of Nifurtimox Tablets for Age‐ and Body Weight‐Adjusted Dosing in Patients With Chagas Disease
por: Stass, Heino, et al.
Publicado: (2020)